UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000059203
Receipt number R000067709
Scientific Title Verification of retention rates for healthy adults in mindfulness seminars
Date of disclosure of the study information 2026/02/01
Last modified on 2025/09/26 14:47:55

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Verification of retention rates in mindfulness seminars

Acronym

Verification of retention rates in mindfulness seminars

Scientific Title

Verification of retention rates for healthy adults in mindfulness seminars

Scientific Title:Acronym

Verification of retention rates for healthy adults in mindfulness seminars

Region

Japan


Condition

Condition

Healthy Adults

Classification by specialty

Adult

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To confirm the retention rate of a newly developed mindfulness seminars

Basic objectives2

Others

Basic objectives -Others

N/A

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Seminar retention rate
Meditation practice status

Key secondary outcomes

Amount of change in sleep efficiency


Base

Study type

Interventional


Study design

Basic design

Parallel

Randomization

Randomized

Randomization unit

Individual

Blinding

Double blind -all involved are blinded

Control

No treatment

Stratification

YES

Dynamic allocation

YES

Institution consideration

Institution is not considered as adjustment factor.

Blocking

NO

Concealment

No need to know


Intervention

No. of arms

2

Purpose of intervention

Prevention

Type of intervention

Behavior,custom

Interventions/Control_1

6-week Mindfulness Program (including online seminars, audio guides, and Fitbit integration)

Interventions/Control_2

Waitlist control group (receives the same recorded seminar after the intervention group, with Fitbit integration)

Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit

75 years-old >

Gender

Male and Female

Key inclusion criteria

1.Healthy men and women aged 20 years or older at the time of obtaining informed consent
2.Individuals enrolled in the NTT Health Insurance Association
3.Individuals with a properly functioning connection to the Fitbit app
4.Individuals who can consent to data acquisition through the use of Fitbit API integration
5.Individuals who can participate in seminars and questionnaires conducted during the research period

Key exclusion criteria

1. Individuals who are not currently using Fitbit and are not expected to use it in the future
2. Individuals who have experienced discomfort during previous meditation sessions or similar activities
3. Individuals who have experienced skin diseases due to wearing Fitbit
4. Individuals who received treatment for mental or sleep disorders at a psychosomatic medicine department in the past two years

Target sample size

200


Research contact person

Name of lead principal investigator

1st name satomi
Middle name
Last name kawakami

Organization

NTT health insurance union

Division name

Headquarters

Zip code

101-0047

Address

17F Urbannet Kanda Building, 3-6-2 Uchikanda, Chiyoda, Tokyo, Japan

TEL

03-6206-4041

Email

satomi.kawakami.tf@ntt-ba.co.jp


Public contact

Name of contact person

1st name satomi
Middle name
Last name kawakami

Organization

NTT health insurance union

Division name

Headquarters

Zip code

101-0047

Address

17F Urbannet Kanda Building, 3-6-2 Uchikanda, Chiyoda, Tokyo, Japan

TEL

03-6206-4041

Homepage URL


Email

satomi.kawakami.tf@ntt-ba.co.jp


Sponsor or person

Institute

NTT health insurance union

Institute

Department

Personal name



Funding Source

Organization

NTT health insurance union

Organization

Division

Category of Funding Organization

Self funding

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

Nihonbashi Sakura Clinic Institutional review board

Address

5F,Inamura Building,1-9-2,Nihonbashikayabacho,Chuo-ku,, Tokyo,Japan

Tel

03-6661-9061

Email

c-irb_ug@neues.co.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2026 Year 02 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Enrolling by invitation

Date of protocol fixation

2025 Year 07 Month 07 Day

Date of IRB

2025 Year 07 Month 16 Day

Anticipated trial start date

2025 Year 10 Month 02 Day

Last follow-up date

2026 Year 01 Month 25 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2025 Year 09 Month 26 Day

Last modified on

2025 Year 09 Month 26 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000067709